In this article, we will take a look at the 13 Best Blue Chip Stocks to Buy Now.

Blue-chip stocks are well-positioned to emerge as the ultimate winners amid the Trump tariffs and a shift in monetary policy. According to Brian Gardner, Chief Washington policy strategist at Stifel Financial, large-cap companies boast of strong negotiating power to navigate the tariff environment. Likewise, he expects the companies to navigate with ease a changing economic environment

”[Small caps] also probably don’t have the ability to negotiate any exemptions. Their ability to pivot from one country to another to maybe arbitrage the tariff risk is probably reduced.” Gardner said.

The remarks come amid growing speculation about a potential rotation in the equity markets, following one of the longest bull runs driven by blue-chip stocks. Goldman Sachs CEO has already warned of a possible 10- to 20% drawdown in the equity market as investors resort to profit-taking.

“A 10 to 15% drawdown happens often, even though positive market cycles. It’s not something that changes your fundamental, your structural belief as to how you want to allocate capital,” said Goldman Sachs CEO David Solomon

Morgan Stanley CEO Ted Pick expects a healthy drawdown that does not signal a market crisis. Such drawdowns would offer investors opportunities to capitalize on pullbacks from current premium valuations. Blue-chip stocks are expected to continue driving the market higher, even during a drawdown, as the US Federal Reserve embarks on a monetary policy easing spree.

Amid heightened valuation concerns with major indices at all-time highs, the focus is slowly shifting towards large-cap stocks trading at discounted valuations, backed by solid underlying fundamentals.

With that in mind, let’s take a look at some of the best blue chip stocks to buy now.

Our Methodology

To identify the best blue chip stocks to buy now, we conducted a detailed review of several prominent blue chip ETFs and recent relevant financial media reports. We shortlisted companies that enjoy strong support from hedge funds, carry favorable analyst sentiment, and have been recently making headlines. Finally, we ranked the selected stocks according to the scale of hedge fund ownership reported in the second quarter of 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

Best Blue Chip Stocks to Buy Now

13. Dell Technologies Inc. (NYSE:DELL)

Number of Hedge Fund Holders: 54

Dell Technologies Inc. (NYSE:DELL) is one of the best blue-chip stocks to buy now. On November 3, analysts at Evercore ISI reiterated an “Outperform” rating on Dell Technologies Inc. (NYSE:DELL) and raised the price target to $180 from $160. The price target hike comes as the research firm expects the company to benefit from a significant order of ancillary equipment.

With IREN inking a 5-year contract worth $9.7 billion with Microsoft for the supply of GB300 GPUs, Dell is poised to attract a $5.8 billion order for ancillary equipment. IREN purchases high-performance AI infrastructure hardware from Dell for its cloud services, which support clients such as Microsoft.

The IREN deal is poised to strengthen Dell’s Tier 2 customer base, which currently includes CoreWeave and xAI. The IREN program is also expected to account for about 25% of Dell’s total AI revenue. As part of the IREN Microsoft deal, Dell is to handle the complete delivery and integration of systems for its customers. Evercore ISI expects the company to capitalize on the expansion of its Tier 2 customer base.

Dell Technologies announced on October 21, that it has advanced its AI Data Platform to help enterprises unlock faster and more reliable insights by breaking down data silos. The platform, part of the Dell AI Factory and integrated with NVIDIA’s reference design, combines storage engines, data engines, cyber resiliency, and management services to support demanding AI workloads. Dell PowerScale and ObjectScale deliver enhanced scalability and performance, with PowerScale offering simplified NAS access and GPU-scale efficiency, while ObjectScale provides high-speed, S3‑native object storage with new software-defined options and deeper AWS integration.

Dell Technologies Inc. (NYSE:DELL) designs, develops, sells, and supports a wide range of computers and IT solutions. Its product line includes laptops, desktops, and monitors, as well as advanced infrastructure solutions such as servers, data storage, and artificial intelligence for businesses.

12. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders: 67

McKesson Corporation (NYSE:MCK) is one of the best blue-chip stocks to buy now. On November 6, Morgan Stanley raised its price target on McKesson Corporation (NYSE:MCK) to $916 from $857, keeping its Overweight rating. Analysts pointed to the company’s strong organic growth and operational momentum reflected in updated guidance, though they noted investor reaction could be restrained given the high expectations already priced in.

A day earlier, on November 5, McKesson posted second‑quarter results for Fiscal 2026. Revenue climbed 10% to $103.2 billion, helped by rising prescription volumes and broader distribution of oncology and multispecialty products. Earnings per share jumped to $8.92, compared with $1.87 a year ago, as the company moved past charges tied to earlier divestitures and restructuring.

Operating cash flow reached $2.4 billion, with free cash flow at $2.2 billion. In the first half of the fiscal year, McKesson returned $1.6 billion to shareholders through buybacks and dividends, underscoring its focus on capital returns.

Looking ahead, the company lifted its adjusted earnings guidance to $38.35–$38.85 per share for Fiscal 2026. CEO Brian Tyler said record revenue and earnings highlight McKesson’s strength in oncology, multispecialty, and biopharma services, adding that the company is well positioned to deliver long‑term value.

McKesson Corporation (NYSE:MCK) is a diversified healthcare services company that distributes pharmaceuticals and medical-surgical supplies.

11. Gilead Sciences, Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 71

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best blue-chip stocks to buy now. On November 3, Bernstein SocGen Group reiterated its “Outperform” rating on Gilead Sciences, Inc. (NASDAQ: GILD), setting a price target of $135. The firm highlighted the company’s solid third-quarter performance and noted continued strength in HIV therapies and emerging treatments as reasons for optimism about future growth.

Earlier, on October 31, Maxim Group analyst Michael Okunewitch maintained a neutral stance, reaffirming a Hold rating. He acknowledged strong HIV sales, particularly from Biktarvy and Yeztugo. However, he raised concerns over limited growth elsewhere, with the oncology unit facing competitive pressures and liver disease still being a smaller contributor. He concluded that Gilead’s reliance on HIV treatments and valuations in line with peers warranted caution.

On October 30, Gilead had reported third‑quarter revenues of $7.8 billion, up 3% from the prior year. Product sales declined 2% to $7.3 billion, primarily due to weaker demand for Veklury and Cell Therapy, although the HIV and liver disease portfolios provided a lift. Earnings per share rose to $2.43 from $1.00 a year earlier, aided by the absence of large impairment charges and a $400 million boost from other revenues.

Gilead has lifted its full‑year outlook, projecting revenue between $28.4 billion and $28.7 billion, slightly higher than its earlier range of $28.3 billion to $28.7 billion. The company now expects earnings per share to come in between $8.05 and $8.25, compared with the prior forecast of $7.95 to $8.25.

Based in Foster City, California, Gilead Sciences (NASDAQ:GILD) is a biopharmaceutical firm known for developing treatments for serious illnesses, including HIV, viral hepatitis, and cancer.

10. CVS Health Corporation (NYSE:CVS)

Number of Hedge Fund Holders:71

CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The move followed management’s updated guidance, which narrowed the expected GAAP diluted loss per share to between $0.24 and $0.34, down sharply from the earlier forecast of $3.84 to $3.94. At the same time, adjusted earnings guidance was raised to $6.55–$6.65 per share, compared with the prior range of $6.30–$6.40.

Just days earlier, on October 29, 2025, CVS Health Corporation reported third‑quarter revenue of $102.9 billion, a 7.8% increase from the previous year and well above the consensus estimate of $98.88 billion.

The company posted a diluted loss per share of $3.13, largely the result of a $5.7 billion goodwill impairment charge tied to its Healthcare Delivery unit. On an adjusted basis, earnings came in at $1.60 per share, up from $1.09 a year earlier, supported by stronger operating income in the Health Care Benefits segment.

“Our leadership team has stabilized operations and is focused on businesses and markets where we can succeed. As a result, we are making progress on our journey to be America’s most trusted health care company. Our strong Enterprise performance demonstrates the continued focus we have on operational and financial improvement across our businesses,” said CEO David Joyner.

CVS Health Corporation (NYSE:CVS) is a healthcare company that operates an integrated healthcare model across several sectors, including pharmacy, retail, health insurance, and pharmacy benefit management.

9. HCA Healthcare, Inc. (NYSE:HCA)

Number of Hedge Fund Holders: 73

HCA Healthcare Inc. (NYSE:HCA) is one of the best blue-chip stocks to buy now. On October 27, analysts at RBC Capital reiterated an Outperform rating on HCA Healthcare Inc. (NYSE:HCA) and raised the price target to $482 from $449. The price target was raised following the company’s strong third‑quarter results, reported on October 24, which came in ahead of expectations.

Revenues in the quarter increased 9.6% year over year to $19.16 billion as net income increased 29.4% to $1.64 billion. Diluted earnings per share increased 42.6% to $6.96 per diluted share. RBC Capital increased its price target after management raised its full-year guidance.

Management expects revenue to range between $75 billion and $76.45 billion, up from the previous guidance of $74.00 billion to $76.00 billion. Net income attributed to shareholders is expected to be between $6.495 billion and $6.715 billion, up from the prior guidance of $6.110 billion to $6.480 billion. Earnings per share are expected to range between $27.00 $28.00 per diluted share, up from the previous guidance of between $25.50 and $27.00 per diluted share.

According to RBC Capital, the strong Q3 performance and guidance upgrade affirm management’s confidence in achieving volume growth in line with long-term targets. The research firm expects strong demographics and expanded patient access to support HCA’s growth prospects in 2026.

HCA Healthcare, Inc. (NYSE:HCA) is a private healthcare provider, operating a vast network of hospitals, outpatient facilities, and other healthcare sites.

8. The Goldman Sachs Group, Inc. (NYSE:GS)

Number of Hedge Fund Holders: 73

The Goldman Sachs Group, Inc. (NYSE:GS) is one of the best blue-chip stocks to buy now. On October 27, reports emerged indicating that The Goldman Sachs Group Inc. (NYSE:GS) is in discussions with the Kuwait Investment Authority (KIA). The investment bank is looking to secure a $10 billion mandate as it seeks to strengthen its asset management arm.

The US investment bank aims to secure $10 billion over the next few years, allocated across multiple funds. Talks with Kuwait’s wealth fund come at a time when Goldman Sachs has been accelerating its push into private markets and alternative asset businesses.

The expansion is part of an effort aimed at shifting away from the traditional revenue mix of trading and into investment banking. While delivering third-quarter results, CEO David Solomon reiterated plans to raise $100 billion in alternative assets, such as real estate, hedge funds, and private credit.

Meanwhile, on November 4, Barclays analyst Jason Goldberg reiterated a “Buy” rating and a $850 price target on the stock.

The Goldman Sachs Group, Inc. (NYSE:GS)is a leading investment banking, securities, and investment management firm.

7. Exxon Mobil Corporation (NYSE:XOM)

Number of Hedge Fund Holders: 88

Exxon Mobil Corporation (NYSE:XOM) is one of the best blue-chip stocks to buy now. On November 11, 2025, Piper Sandler raised its price target on Exxon Mobil Corporation (NYSE:XOM) to $144 from $141, maintaining an Overweight rating. The firm noted that while crude oil worries continue to weigh on sentiment, Exxon’s third‑quarter results underscore resilient cash flow, steady growth, and ongoing cost savings that are lowering breakeven levels.

Earlier on October 31, ExxonMobil Corp delivered strong third-quarter results, characterized by the highest earnings per share in recent history, amid record production in Guyana.

The company reported earnings of $7.5 billion, or $1.76 per share, despite facing weak crude prices, higher depreciation, and lower base volumes resulting from strategic divestments. Year-to-date earnings totaled $22.3 billion compared to $26.1 billion for the same period last year. The decline was partially offset by volume growth in the Permian basin and Guyana.

During the quarter, the company reaffirmed its commitment to shareholder value by returning $9.4 billion, comprising $4.2 billion in dividends and $5.1 billion in share repurchases. ExxonMobil also declared a fourth-quarter dividend of $1.03 per share, representing a 4% increase. The dividend is to be paid on December 10 to shareholders of record as of November 14. The dividend offering comes on the heels of the company generating a strong year-to-date cash flow from operations of $39.3 billion and free cash flow of $20.6 billion as of the third quarter.

Exxon Mobil Corporation (NYSE:XOM) is an integrated energy company that explores for, produces, and refines oil and natural gas, while also operating a large chemical business. It transforms hydrogen and carbon molecules into a wide range of products, including fuels and chemicals used in the manufacturing of modern goods such as polymers, plastics, and synthetic lubricants.

6. Alibaba Group Holding Limited (NYSE:BABA)

Number of Hedge Fund Holders: 101

Alibaba Group Holding (NYSE:BABA) is one of the best blue-chip stocks to buy now. On October 22, analysts at Mizuho reiterated an “Outperform” rating on Alibaba Group Holding (NYSE:BABA) and raised the price target to $195 from $159.

The price target hike comes amid expectations that the company is on track to deliver a strong summer, with an extremely high volume of delivery orders. The research firm expects the company to benefit from increased incentives. Additionally, Mizuho expects Alibaba to gain market share in the banking sector due to its full-stack artificial intelligence offerings.

In addition to pushing for growth in the banking sector, Alibaba is also expanding its footprint into the robotaxi business. On November 5, Chinese EV manufacturer Xpeng announced it will partner with Alibaba’s mapping unit Amap to roll out a new robotaxi service. The two are joining forces to launch three self-driving robotaxi models ahead of trial operations next year. The integration of driverless cars into Amap’s platform will also pave the way for the development of a global robotaxi service network.

Alibaba Group Holding Limited (NYSE:BABA) is a technology company that operates primarily in e-commerce, cloud computing, and online payment services.

5. Citigroup Inc. (NYSE:C)

Number of Hedge Fund Holders: 102

Citigroup Inc. (NYSE:C) is one of the best blue-chip stocks to buy now. On November 7, Barclays analyst Jason Goldberg reaffirmed his Buy rating on Citigroup Inc. (NYSE:C) and set a price target of $115. On October 30, Citigroup Inc. lowered its base lending rate to 7% from 7.25%. The cut highlights the bank’s effort to make borrowing more attractive amid economic uncertainty and intense competition in the banking industry.

The 25 basis point cut, which comes on the heels of the US Federal Reserve cutting its benchmark rate to 4% also reflects Citigroup’s bid to attract new borrowers and retain existing clients. Additionally, the cut could result in significant savings for consumers and businesses with loans tied to the bank’s base rate.

Meanwhile, on October 15, KBW analyst Christopher Mcgratty reiterated a Buy rating on the stock. The analyst also set a $118 price target on the stock. The Buy rating follows solid third-quarter results on October 14, characterized by record revenue despite the company booking a loss from the sale of stakes in a Mexican unit. Revenues in the quarter rose 9% to $22.09 billion, exceeding consensus estimates of $21.09 billion, as net income jumped 16% to $3.75 billion, or $1.86 per share.

Citigroup Inc. (NYSE:C) is a major multinational investment bank and financial services corporation that provides a broad range of financial products and services to consumers, corporations, governments, and institutions worldwide.

4. Bank of America Corporation (NYSE:BAC)

Number of Hedge Fund Holders: 115

Bank of America Corporation (NYSE:BAC) is one of the best blue-chip stocks to buy now.  On November 6, analysts at Morgan Stanley raised the stock’s price target to $70 from $67, citing the company’s provision of a clear path to Return on Tangible Common Equity (ROTC) growth of between 16% and 18%. Likewise, the investment bank reiterated an Overweight rating on the stock.

According to Morgan Stanley, Bank of America Corporation (NYSE:BAC) is well positioned to outperform as net interest income headwinds become tailwinds. The firm also expects a new period of operating leverage.

RBC Capital Analyst Gerard Cassidy shares similar sentiments, reiterating an Outperform rating on the stock and a $56 price target on November 11. The RBC Capital analyst has echoed Bank of America’s growth strategy, which remains unchanged, with prospects for new profitability and efficiency targets. The research firm expects the bank to achieve its medium-term targets as it focuses on innovation and operational excellence.

Bank of America Corporation (NYSE:BAC) is a multinational financial institution that services individual consumers, small and middle-market businesses, and large corporations. Its services include retail banking, investing, wealth management, commercial banking, and global corporate and investment banking, which encompasses treasury, lending, and debt and equity underwriting.

3. JPMorgan Chase & Co. (NYSE:JPM)

Number of Hedge Fund Holders: 124

JPMorgan Chase & Co. (NYSE:JPM) is one of the best blue-chip stocks to buy now. On November 11, Moody’s upgraded JPMorgan Chase & Co.’s (NYSE:JPM) long-term deposit rating to Aa1 from Aa2. The upgrade is in response to the bank’s superior financial performance, driven by steady growth in client engagement and industry-leading profitability.

The investment bank delivered solid third-quarter results with profit jumping 12% to $14.39 billion as earnings per share totaled $5.07. Revenue increased by 9% to $47.12 billion, affirming the strong financial position. Moody’s also upgraded the bank’s baseline credit assessment to a1 from a2 buoyed by the strong financial position. With the upgrade, JPMorgan is one of Moody’s highest-rated banks, signaling its well-positioned to outperform its peers regardless of the prevailing economic cycles.

On November 3, analysts at Wells Fargo raised the stock’s price target to $350 from $345 while reiterating an Overweight rating. According to analysts, JPMorgan is one of the best global banks, thanks to its market share gains and focus on organic growth.

JPMorgan Chase & Co (NYSE:JPM) is a financial services company that offers investment and commercial banking, asset, and wealth management services. It serves individuals, small businesses, large corporations, institutions, and governments worldwide.

2. Tesla, Inc. (NASDAQ:TSLA)

Number of Hedge Fund Holders: 115

Tesla Inc. (NASDAQ:TSLA) is one of the best blue-chip stocks to buy now. On November 11, analysts at Truist Securities expressed confidence in Tesla Inc.’s (NASDAQ:TSLA) prospects following the approval of $1 trillion equity compensation for Chief Executive Officer Elon Musk. The research firm reiterated a Hold rating and a $406 price target, citing confidence that the equity compensation removes the uncertainty of Musk leaving the company.

On November 3, Wedbush reiterated an Outperform rating on the stock and a $600 price target, expecting that under Musk’s leadership, with the $1 trillion compensation in place, the company will become an AI juggernaut. The massive payout is based on Tesla achieving extraordinary market cap, operational, and AI-driven milestones.

Among the goals that Musk must achieve as part of the $1 trillion payout are ensuring Tesla delivers 20 million vehicles, 10 million active Full Self-Driving subscriptions, and 1 million robotaxis in commercial operation.

Tesla Inc. (NASDAQ:TSLA) is an electric vehicle company that utilizes AI to power its autonomous driving systems, manage its manufacturing and factories, and develop new products, such as the Optimus humanoid robot. The company leverages a massive dataset from its vehicle fleet to train these AI systems and also develops its own AI hardware.

1. Microsoft Corporation (NASDAQ:MSFT)

Number of Hedge Fund Holders: 294

Microsoft Corporation (NASDAQ:MSFT) is one of the best blue-chip stocks to buy now. On November 5, Microsoft Corporation (NASDAQ:MSFT) entered into a strategic partnership with Pantone, a digital solutions provider for the creative and design communities. The two are joining forces to support designers in utilizing artificial intelligence to enhance their craft.

As part of the partnership, Pantone has unveiled the beta version of the Pantone Palette Generator, built on Microsoft Azure OpenAI, to leverage expertise in color psychology and trend forecasting. The AI-powered platform is designed to streamline color decision-making and communication while leveraging decades of expertise and research from the color and trend experts at the Pantone Color Institute.

“Pantone is showing the world what it means to lead with AI — transforming an industry long grounded in physical design,” said Kathleen Mitford, corporate vice president, Global Industry Marketing at Microsoft. “Together, we’re accelerating design workflows with Azure OpenAI and showcasing how AI can unlock new levels of creativity, productivity and innovation across every industry.”

Just a few days earlier, on October 31, analysts at Truist Securities reaffirmed their Buy rating on Microsoft and raised confidence in the stock with a $675 price target. The call followed the company’s release of its first‑quarter fiscal 2026 results. The positive stance underscores the research firm’s confidence in Microsoft’s Azure cloud platform and its momentum in commercial bookings. Microsoft’s first‑quarter fiscal 2026 results beat expectations, with overall revenue rising 17% in constant currency against forecasts of 14%. The standout was Azure, which delivered 39% growth, topping consensus by two points.

Microsoft Corporation (NASDAQ:MSFT) is a software application company that uses AI to enhance its existing product lines with intelligent features, offer a comprehensive cloud platform for developers to build their own AI solutions, and conduct cutting-edge research in the field.

READ NEXT: Top 9 Undervalued Asset Management Stocks to Buy and 13 Best AI Stocks to Buy Under $20.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.